QIAGEN NV (QGEN)
49.75
-0.06
(-0.12%)
USD |
NYSE |
Nov 17, 16:00
49.75
0.00 (0.00%)
After-Hours: 17:56
QIAGEN Enterprise Value : 11.10B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 11.10B |
| November 13, 2026 | 11.11B |
| November 12, 2026 | 11.16B |
| November 11, 2026 | 11.20B |
| November 10, 2026 | 11.24B |
| November 09, 2026 | 11.25B |
| November 06, 2026 | 11.21B |
| November 05, 2026 | 11.32B |
| November 04, 2026 | 11.31B |
| November 03, 2026 | 11.22B |
| November 02, 2026 | 11.21B |
| October 30, 2026 | 11.18B |
| October 29, 2026 | 11.21B |
| October 28, 2026 | 11.21B |
| October 27, 2026 | 11.17B |
| October 26, 2026 | 11.21B |
| October 23, 2026 | 11.22B |
| October 22, 2026 | 11.18B |
| October 21, 2026 | 11.14B |
| October 20, 2026 | 10.91B |
| October 19, 2026 | 10.43B |
| October 16, 2026 | 10.34B |
| October 15, 2026 | 10.35B |
| October 14, 2026 | 10.22B |
| October 13, 2026 | 10.20B |
| Date | Value |
|---|---|
| October 12, 2026 | 10.17B |
| October 09, 2026 | 10.18B |
| October 08, 2026 | 10.01B |
| October 07, 2026 | 10.06B |
| October 06, 2026 | 10.24B |
| October 05, 2026 | 10.27B |
| October 02, 2026 | 10.05B |
| October 01, 2026 | 9.494B |
| September 30, 2026 | 9.849B |
| September 29, 2026 | 10.02B |
| September 28, 2026 | 10.14B |
| September 25, 2026 | 9.973B |
| September 24, 2026 | 10.05B |
| September 23, 2026 | 9.876B |
| September 22, 2026 | 9.872B |
| September 21, 2026 | 10.10B |
| September 18, 2026 | 9.798B |
| September 17, 2026 | 10.01B |
| September 16, 2026 | 9.709B |
| September 15, 2026 | 9.622B |
| September 14, 2026 | 9.498B |
| September 11, 2026 | 9.626B |
| September 10, 2026 | 9.550B |
| September 09, 2026 | 9.626B |
| September 08, 2026 | 9.601B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Illumina, Inc. | 31.07B |
| Thermo Fisher Scientific, Inc. | 291.58B |
| Bio-Rad Laboratories, Inc. | 9.385B |
| Agilent Technologies, Inc. | 50.95B |
| Waters Corp. | 49.46B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 105.66M |
| Revenue (Quarterly) | 547.87M |
| Total Expenses (Quarterly) | 442.21M |
| EPS Diluted (Quarterly) | 0.5078 |
| Gross Profit Margin (Quarterly) | 64.31% |
| Profit Margin (Quarterly) | 19.29% |
| Earnings Yield | 3.72% |
| Operating Earnings Yield | 5.14% |
| Normalized Earnings Yield | 4.278 |